OmniAb (OABI) Deferred Taxes (2022 - 2026)
OmniAb (OABI) reported Deferred Taxes of $442000.0 for Q1 2026, up 516.98% year-over-year from $71639.1 in Q1 2025, and up 216.01% on a QoQ basis from -$381000.0 in Q4 2025.
OmniAb (OABI) has 5 years of Deferred Taxes data on file, last reported at $442000.0 in Q1 2026.
- Quarterly Deferred Taxes rose 516.98% year-over-year to $442000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$981000.0 (up 84.97% YoY) and the FY2025 annual result came in at -$1.5 million, up 83.09% from the prior year.
- Deferred Taxes climbed to $442000.0 in Q1 2026 per OABI's latest filing, from -$381000.0 in the prior quarter.
- Across five years, Deferred Taxes topped out at $442000.0 in Q1 2026 and bottomed at -$5.1 million in Q4 2023.
- The 5-year median for Deferred Taxes is -$1.9 million (2024), against an average of -$1.7 million.
- The widest annual swing landed in 2023, when Deferred Taxes sank 1304.99%; it then surged 516.98% in 2026.
- Tracing OABI's Deferred Taxes over 5 years: stood at $421000.0 in 2022, then slumped by 1304.99% to -$5.1 million in 2023, then soared by 64.18% to -$1.8 million in 2024, then jumped by 79.03% to -$381000.0 in 2025, then surged by 216.01% to $442000.0 in 2026.
- Per Business Quant, the three latest OABI Deferred Taxes figures stand at $442000.0 (Q1 2026), -$381000.0 (Q4 2025), and -$1.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -859,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -65.30 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 96.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 9.31 Mn |
| 10 | OmniAb | 334.72 Mn | 291.75 Mn | 14.41 Mn | 442,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 442,000.00 |
| Dec 31, 2025 | -381,000.00 |
| Sep 30, 2025 | -1.16 Mn |
| Jun 30, 2025 | 119,000.00 |
| Mar 31, 2025 | -106,000.00 |
| Dec 31, 2024 | -1.82 Mn |
| Sep 30, 2024 | -2.71 Mn |
| Jun 30, 2024 | -1.90 Mn |
| Mar 31, 2024 | -2.62 Mn |
| Dec 31, 2023 | -5.07 Mn |
| Sep 30, 2023 | -3.32 Mn |
| Jun 30, 2023 | -3.21 Mn |
| Mar 31, 2023 | -941,000.00 |
| Dec 31, 2022 | 421,000.00 |
| Sep 30, 2022 | -2.36 Mn |
| Jun 30, 2022 | -2.46 Mn |
| Mar 31, 2022 | -2.02 Mn |